. 2016 Dec 29;15(2):613–626. doi: 10.3892/mmr.2016.6083

Table III.

Comparison ofrelativeproteinexpression levels in the control, model and YGD groups.

Group	n	a-SMA	CXCR4	ERK1	ERK2	NF-κB p65	β-catenin
Control	20	0.945±0.013	0.277±0.019	0.115±0.011	0.313±0.014	0.728±0.003	0.567±0.008
Model week 4	10	7.351±0.051^a	0.312±0.014	0.373±0.011^a	0.579±0.002^a	4.211±0.021^a	2.376±0.024^a
YGD week 1	10	4.309±0.006^a,b	0.356±0.008^a,b	0.482±0.020^a,b	0.687±0.025^a,b	2.803±0.005^a,b	1.842±0.006^a,b
YGD week 2	10	3.188±0.017^a,b,c	0.523±0.002^a,b,c	0.610±0.017^a,b,c	1.413±0.025^a,b,c	1.765±0.005^a,b,c	1.189±0.013^a,b,c
YGD week 3	10	2.647±0.010^a,b,d	0.829±0.004^a,b,d	0.685±0.032^a,b,d	1.617±0.020^a,b,d	0.801±0.007^a,b,d	0.784±0.008^a,b,d
YGD week 4	14	1.103±0.022^a,b,e	1.205±0.010^a,b,e	1.125±0.080^a,b,e	2.992±0.141^a,b,e	0.742±0.002^a,b,e	0.569±0.001^b,e

Data are presented as the mean ± standard deviation.

P<0.05 vs. control

P<0.05 vs. model week 4

P<0.05 vs. YGD week 1

P<0.05 vs. YGD week 2

P<0.05 vs. YGD week 3. YGD, Yi GuanJian decoction; α-SMA, α-smooth muscle actin; CXCR4, C-X-C chemokine receptor type 4; ERK1/2, extracellular signal-regulated kinase 1/2; NF-κB p65, nuclear factor κB p65 subunit.